article thumbnail

The impact of AI and ML on the future of drug discovery  

Drug Discovery World

Over the past several years, Dr Jo Varshney , Founder of VeriSIM Life, has front-led numerous collaborative engagements with a host of biopharma companies, government agencies, academic/medical institutes and industry innovators. Here, she discusses with DDW’s Megan Thomas the impact of AI and ML on the drug discovery process.

Drugs 111
article thumbnail

A winning combination: The benefits of micronization and containment in a single installation

Pharmaceutical Technology

The number of high-potency drug approvals has increased over the last decade, driven by the increasing use of APIs (Active Pharmaceutical Ingredients) in the pipeline and among marketed drugs. Premium specialized equipment is necessary because high containment facilities call for the separation of the operator from the product.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Welsh startup Antiverse raises $2m for antibody discovery toolkit

pharmaphorum

The Cardiff, Wales startup is combining machine learning and phage display techniques to model antibody-antigen binding and says it can cut the time it takes to develop a drug candidate. It’s one of the few AI drug discovery companies operating in the antibody category, as most are focused on small molecules.

article thumbnail

Fibrosis research: Advances and challenges 

Drug Discovery World

Wigerinck has taken four drugs (Prezista, Olysio, Jyseleca and Rekambys) to market. Phase I of the clinical program will dose healthy volunteers with single ascending doses of FIB992 before proceeding to a multiple ascending dose study where the drug is administered for a two-week period. That part of the program looks easy.

article thumbnail

Lilly adds to pain pipeline with Asahi Kasei licensing deal

pharmaphorum

US drugmaker Eli Lilly – still waiting for an FDA decision on one non-opioid pain drug – has just added another to its pipeline via a licensing agreement with Japan’s Asahi Kasei worth up to $410 million. While tanezumab is an antibody and has to be delivered by subcutaneous injection, AK1780 is orally bioavailable.

article thumbnail

Warrior's Secret

The Pharma Data

I also started to have some dizziness and nausea from the drugs so I looked for another solution…. I also started to have some dizziness and nausea from the drugs so I looked for another solution…. You can get these benefits without the dangerous side effects and crippling expense of erection drugs….